{"id":"https://openalex.org/W7225609692","doi":"https://doi.org/10.5281/zenodo.24089059","title":"ADVANCES IN LIPOSOME-BASED TARGETED DRUG DELIVERY FOR BREAST CANCER THERAPY","display_name":"ADVANCES IN LIPOSOME-BASED TARGETED DRUG DELIVERY FOR BREAST CANCER THERAPY","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225609692","doi":"https://doi.org/10.5281/zenodo.24089059"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.24089059","doi":"https://doi.org/10.5281/zenodo.24089059","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24089059","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.24089059","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161350679","display_name":"Pavani Chitakani*","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Pavani Chitakani*","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5161350679"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10958","display_name":"Ultrasound and Hyperthermia Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liposomes","display_name":"liposomes","score":0.7789999842643738},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.9649999737739563},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/pegylated-liposomal-doxorubicin","display_name":"pegylated liposomal doxorubicin","score":0.9359999895095825},{"id":"https://openalex.org/keywords/enhanced-permeability-and-retention-effect","display_name":"enhanced permeability and retention effect","score":0.8809999823570251},{"id":"https://openalex.org/keywords/nanotechnology-in-drug-delivery","display_name":"nanotechnology drug delivery","score":0.6320000290870667},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.652999997138977},{"id":"https://openalex.org/keywords/chemotherapy-side-effects","display_name":"chemotherapy side effects","score":0.8679999709129333},{"id":"https://openalex.org/keywords/tumor-targeting-ligands","display_name":"tumor-targeting ligands","score":0.7490000128746033},{"id":"https://openalex.org/keywords/therapeutic-index","display_name":"therapeutic index","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7731999754905701},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6579999923706055},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.6319000124931335},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.5968999862670898},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.5698000192642212},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5393000245094299},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48069998621940613},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.46549999713897705},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.45210000872612},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4499000012874603},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.44920000433921814},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.4404999911785126},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.4316999912261963},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3700999915599823},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.3682999908924103},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.3384000062942505},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3018999993801117},{"id":"https://openalex.org/C15083742","wikidata":"https://www.wikidata.org/wiki/Q261659","display_name":"Nanomedicine","level":3,"score":0.29580000042915344},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.27869999408721924},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.2745000123977661},{"id":"https://openalex.org/C3020340455","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Cancer drugs","level":3,"score":0.25940001010894775},{"id":"https://openalex.org/C3020391286","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapeutic drugs","level":3,"score":0.25049999356269836}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.24089059","doi":"https://doi.org/10.5281/zenodo.24089059","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24089059","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.24089060","doi":"https://doi.org/10.5281/zenodo.24089060","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24089060","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.24089059","doi":"https://doi.org/10.5281/zenodo.24089059","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24089059","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7134936258","https://openalex.org/W2942708344","https://openalex.org/W3197841857","https://openalex.org/W1953084655","https://openalex.org/W4417289464","https://openalex.org/W7166889675","https://openalex.org/W1987609206","https://openalex.org/W6911743088","https://openalex.org/W7128959091","https://openalex.org/W4409208219"],"abstract_inverted_index":{"Breast":[0],"cancer":[1,7,26,108,129],"is":[2,12,27],"a":[3,13],"prevalent":[4],"form":[5],"of":[6,20,59,103,112,144],"in":[8,128,153,161],"women":[9],"globally":[10],"and":[11,42,74,80,167,171],"significant":[14],"public":[15],"health":[16],"problem.":[17],"The":[18],"use":[19],"conventional":[21],"chemotherapy":[22],"to":[23,45,70,77,99,124,139],"treat":[24],"breast":[25,107],"common,":[28],"but":[29],"can":[30],"have":[31,63,122,125],"some":[32],"dire":[33],"side":[34],"effects,":[35],"lack":[36],"drug":[37,49,133,151],"selectivity,":[38],"cause":[39,43],"multidrug":[40],"resistance":[41],"damage":[44],"healthy":[46],"cells.":[47,109],"Nanotechnology":[48],"delivery":[50,134],"systems":[51,135],"are":[52],"now":[53],"emerging":[54],"as":[55,117],"the":[56,101,104,137,141,150,159],"possible":[57],"solutions":[58],"these":[60,68],"challenges.":[61],"Liposomes":[62],"attracted":[64],"much":[65],"interest":[66],"among":[67],"due":[69],"their":[71,75],"biocompatibility,":[72],"biodegradability":[73],"capacity":[76],"deliver":[78],"hydrophilic":[79],"lipophilic":[81],"drugs.":[82],"Additionally,":[83],"targeted":[84,89],"liposomal":[85,119],"drugs":[86,105,115],"may":[87],"be":[88],"with":[90,106],"various":[91],"ligands,":[92],"antibodies,":[93],"peptides":[94],"or":[95],"other":[96],"targeting":[97,174],"molecules":[98],"enhance":[100,140],"interaction":[102],"Liposomal":[110],"formulations":[111],"clinically":[113],"proven":[114,123],"such":[116],"pegylated":[118],"doxorubicin":[120],"(PLD)":[121],"important":[126],"applications":[127],"therapy.":[130],"Liposome":[131],"based":[132],"offer":[136],"potential":[138],"therapeutic":[142],"index":[143],"anti-cancer":[145],"agents,":[146],"either":[147],"by":[148,157,172],"increasing":[149],"concentration":[152],"tumor":[154],"cells":[155],"and/or":[156],"decreasing":[158],"exposure":[160],"normal":[162],"tissues":[163],"exploiting":[164],"enhanced":[165],"permeability":[166],"retention":[168],"effect":[169],"phenomenon":[170],"utilizing":[173],"strategies.":[175]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}